Diflunisal (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Diflunisal drug offered from Cadila Healthcare Limited. This Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
NON-PROPRIETARY NAME: | Diflunisal |
SUBSTANCE NAME: | DIFLUNISAL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-09-14 |
END MARKETING DATE: | 0000-00-00 |
Diflunisal HUMAN PRESCRIPTION DRUG Details:
Item Description | Diflunisal from Cadila Healthcare Limited |
LABELER NAME: | Cadila Healthcare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/1) |
START MARKETING DATE: | 2017-09-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70771-1083_aa36dffd-e56d-43a9-ab2e-c2a6005c8b2b |
PRODUCT NDC: | 70771-1083 |
APPLICATION NUMBER: | ANDA203547 |
Other DIFLUNISAL Pharmaceutical Manufacturers / Labelers: